Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Organ Preservation with Cetuximab and Radiation in Laryngeal Cancer
NCT00599131Phase 2Terminated
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Aug 2007
- Primary completion
- Jul 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in laryngeal cancer, sponsored by University of Michigan Rogel Cancer Center. Started Aug 2007; status: terminated.
02
Drugs
KL-140
03
Conditions
laryngeal cancer
Beyond the preview
Go deeper on NCT00599131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00599131.